38 results on '"Brandi, G"'
Search Results
2. Bile cell‑free DNA: a game changer for management of biliary tract cancer?
3. A38 - Focus on metastatic right-sided colon cancer: the best overall response to the first-line non-EGFR treatment correlates with better overall survival
4. 181P A randomized controlled trial on the efficacy of supervised exercise training in reducing IGF-1 levels in breast cancer survivors of the Movis’ cohort
5. 59P Efficacy of derazantinib in intrahepatic cholangiocarcinoma (iCCA) patients with FGFR2 fusions, mutations or amplifications
6. P-144 Quality of life assessment in biliary tract cancer: A systematic review of phase 2 and 3 clinical trials published between 2010 and 2021
7. Cancer surveillance in ulcerative colitis: critical analysis of long-term prospective programme
8. 47P Derazantinib for patients with intrahepatic cholangiocarcinoma harboring FGFR2 fusions/rearrangements: Primary results from the phase II study FIDES-01
9. P-69 Intensive follow-up program and oncological outcomes of 278 biliary tract cancer patients after curative intent surgery: A single-center retrospective experience
10. Real-life clinical data of cabozantinib for unresectable hepatocellular carcinoma: efficacy, safety and prognostic factors
11. T02.01.19 EFFICACY OF PREMEDICATION WITH SYMETICHONE AND N-ACETYLCYSTEINE IN IMPROVING VISIBILITY DURING UPPER GI ENDOSCOPY: A RANDOMIZED CONTROLLED TRIAL
12. 65P Prognostic role of PECS2 index in advanced biliary tract cancer (BTC) patients treated with first line chemotherapy: Training and validation cohorts
13. 57P Third-line chemotherapy in advanced biliary cancers (ABC): Pattern of care, treatment outcome and prognostic factors from a multicenter study
14. 999P Real-life clinical data of cabozantinib for unresectable hepatocellular carcinoma
15. 238P Beneficial effects of exercise in oncology - MoviS: ‘Movement and Health Beyond Care’
16. PD-2 Role of pretreatment SUVmax on 18F-FDG PET and clinicopathological features in the prognostic stratification of newly diagnosed intrahepatic cholangiocarcinoma
17. P-23 Microwave ablation versus radiofrequency ablation in BCLC-A hepatocellular carcinoma: A systematic review and meta-analysis of randomized controlled trials
18. P-19 Role of percutaneous radiofrequency ablation in unresectable, non-metastatic intrahepatic cholangiocarcinoma: A single-institution experience
19. 65P - Potentially actionable mutations in intrahepatic cholangiocarcinoma
20. 757P - Efficacy and safety of ramucirumab (RAM) for advanced hepatocellular carcinoma (HCC) with elevated alpha-fetoprotein (AFP) following first-line sorafenib across age subgroups in two global phase III trials (REACH and REACH-2)
21. 753P - Prognostic and predictive value of baseline alpha-fetoprotein (AFP) in patients with advanced hepatocellular carcinoma (HCC) treated with ramucirumab from two phase III studies (REACH, REACH-2)
22. 149O - Efficacy and safety of ramucirumab (RAM) in Asian and non-Asian patients with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP): Subgroup analysis from two randomized studies
23. 765P - Prediction of overall survival with 2nd-line (L2OS) chemotherapy (CT) in patients with advanced biliary tract cancer (aBTC): AGEO CT2BIL cohort update and international multicenter external validations
24. 764P - Advanced intrahepatic cholangiocarcinoma (iCCA) treated with arterial-directed therapies (ADT): Outcomes and safety from a multicenter Italian experience
25. D12 - Whole-exome sequencing analysis identifies recurrent mutation rate in BAP1 gene in intrahepatic cholangiocarcinoma patients exposed to asbestos
26. D8 - Biliary tract carcinoma and chronic viral hepatitis in Italy: the GICO (Gruppo Italiano COlangiocarcinoma) experience
27. A26 - Radically resected stage III colorectal cancer: sidedness and prognosis
28. Clinical patterns of hepatocellular carcinoma (HCC) in non alcoholic fatty liver disease (NAFLD): a multicenter case-control study
29. Second-line chemotherapy in advanced biliary cancer: the present now will later be past
30. CS.01.3 THE EMERGING IMPACT OF HCC-NAFLD IN ITALY
31. OC-26 The emerging impact of HCC-NAFLD in Italy
32. 20 P Omeprazole therapy induce the ultrastructural healing in acid reflux oesophagitis. A preliminary report
33. 21 P Dilated intercellular spaces of human oesophageal epithelium as the first and most sensitive marker of damage in acid reflux oesophagitis
34. Carboplatin (CBDCA) and paclitaxel (TAX) as induction chemotherapy in stage IIIA–IIIB in non small cell lung cancer (NSCLC)
35. The effect of histidine on the cytotoxicity of hydrogen peroxide in cultured mammalian and bacterial cells
36. L-histidine promotes the formation of DNA double strand breaks and triggers apoptosis in U937 cells exposed to hydrogen peroxide
37. A human myeloid leukemia (U937) cell line is uniquely sensitive to the cytotoxic effect of ascorbate
38. A Mixed-apprOach program To help women wIth breast cancer stay actiVE (MOTIVE program): A pilot-controlled study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.